Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Price:
0.9778 USD
4.41%
Market Closed
Updated:
Jun 3, 2024
Rigel Pharmaceuticals Inc
Change in Working Capital
|
Rigel Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rigel Pharmaceuticals Inc
NASDAQ:RIGL
|
Change in Working Capital
$1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Rigel Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
1.4m
USD
1.4m
USD
Based on the financial report for Mar 31, 2024, Rigel Pharmaceuticals Inc's Change in Working Capital amounts to 1.4m USD.
What is Rigel Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-40%
-40%
You don't have any saved screeners yet
